Dual-Time-Point 18 F-FDG PET/CT for Differentiating a Chest Wall Hemangioma From a Malignant Metastasis

Hsi Huei Lu; Nan Tsing Chiu

doi:10.1097/RLU.0000000000004536

Dual-Time-Point 18 F-FDG PET/CT for Differentiating a Chest Wall Hemangioma From a Malignant Metastasis

Hsi Huei Lu, Nan Tsing Chiu

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

ABSTRACT: Dual-time-point 18 F-flluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) can be used to differentiate benign vascular tumors from other malignant growths. We present the case of a 70-year-old woman with a history of cervical carcinoma who was referred for PET/CT to examine a left chest wall tumor noted on CT, which involved the adjacent rib and pleura, thus raising the suspicion of metastasis. The chest wall tumor demonstrated moderate FDG uptake and further decreased uptake at the delayed-phase scanning, corresponding to biodistribution of FDG in the blood pool. These findings indicated a benign hemangioma rather than a metastasis.

Original language	English
Pages (from-to)	332-334
Number of pages	3
Journal	Clinical Nuclear Medicine
Volume	48
Issue number	4
DOIs	https://doi.org/10.1097/RLU.0000000000004536
Publication status	Published - 2023 Apr 1

All Science Journal Classification (ASJC) codes

Radiology Nuclear Medicine and imaging

Access to Document

10.1097/RLU.0000000000004536

Cite this

@article{c7f65722ac34437caf8596cf55b97beb,

title = "Dual-Time-Point 18 F-FDG PET/CT for Differentiating a Chest Wall Hemangioma From a Malignant Metastasis",

abstract = "ABSTRACT: Dual-time-point 18 F-flluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) can be used to differentiate benign vascular tumors from other malignant growths. We present the case of a 70-year-old woman with a history of cervical carcinoma who was referred for PET/CT to examine a left chest wall tumor noted on CT, which involved the adjacent rib and pleura, thus raising the suspicion of metastasis. The chest wall tumor demonstrated moderate FDG uptake and further decreased uptake at the delayed-phase scanning, corresponding to biodistribution of FDG in the blood pool. These findings indicated a benign hemangioma rather than a metastasis.",

author = "Lu, {Hsi Huei} and Chiu, {Nan Tsing}",

year = "2023",

month = apr,

day = "1",

doi = "10.1097/RLU.0000000000004536",

language = "English",

volume = "48",

pages = "332--334",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Dual-Time-Point 18 F-FDG PET/CT for Differentiating a Chest Wall Hemangioma From a Malignant Metastasis

AU - Lu, Hsi Huei

AU - Chiu, Nan Tsing

PY - 2023/4/1

Y1 - 2023/4/1

N2 - ABSTRACT: Dual-time-point 18 F-flluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) can be used to differentiate benign vascular tumors from other malignant growths. We present the case of a 70-year-old woman with a history of cervical carcinoma who was referred for PET/CT to examine a left chest wall tumor noted on CT, which involved the adjacent rib and pleura, thus raising the suspicion of metastasis. The chest wall tumor demonstrated moderate FDG uptake and further decreased uptake at the delayed-phase scanning, corresponding to biodistribution of FDG in the blood pool. These findings indicated a benign hemangioma rather than a metastasis.

AB - ABSTRACT: Dual-time-point 18 F-flluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) can be used to differentiate benign vascular tumors from other malignant growths. We present the case of a 70-year-old woman with a history of cervical carcinoma who was referred for PET/CT to examine a left chest wall tumor noted on CT, which involved the adjacent rib and pleura, thus raising the suspicion of metastasis. The chest wall tumor demonstrated moderate FDG uptake and further decreased uptake at the delayed-phase scanning, corresponding to biodistribution of FDG in the blood pool. These findings indicated a benign hemangioma rather than a metastasis.

UR - http://www.scopus.com/inward/record.url?scp=85149179113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149179113&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000004536

DO - 10.1097/RLU.0000000000004536

M3 - Article

C2 - 36728134

AN - SCOPUS:85149179113

SN - 0363-9762

VL - 48

SP - 332

EP - 334

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

IS - 4

ER -

Dual-Time-Point 18 F-FDG PET/CT for Differentiating a Chest Wall Hemangioma From a Malignant Metastasis

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this